Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
| Status: | Active, not recruiting |
|---|---|
| Conditions: | High Cholesterol, Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/7/2019 |
| Start Date: | February 3, 2017 |
| End Date: | December 31, 2019 |
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
The purpose of this study is to see if bempedoic acid (ETC-1002) is safe and well-tolerated
in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately
controlled by their current therapy.
in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately
controlled by their current therapy.
Inclusion Criteria:
- Successfully completed CLEAR Harmony (1002-040) parent study
Exclusion Criteria:
- Experienced a treatment-related SAE that led to study drug discontinuation in the
CLEAR Harmony (1002-040) parent study.
- Medical condition requires lipid measurement and/or adjustment of background
lipid-regulating therapy.
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials